(Q33986493)

30 July 2017

title

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation (English)

1 reference

30 July 2017

main subject

liver transplantation

1 reference

1 reference

Wladimiro Jiménez

5

0 references

Pere Ginès

object named as

Pere Ginès

8

0 references

Vicente Arroyo

object named as

Vicente Arroyo

6

0 references

Joan Rodés Teixidor

7

object named as

Juan Rodés

1 reference

30 July 2017

2

Osman Ozdogan

1 reference

30 July 2017

4

Tea Restuccia

1 reference

30 July 2017

Carlo Alessandria

1

1 reference

30 July 2017

Mónica Guevara

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

30 July 2017

1 reference

30 July 2017

volume

41

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

1282-1289

1 reference

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

30 July 2017

cites work

1 reference

Body fluid volume regulation in health and disease: a unifying hypothesis

21 January 2018

1 reference

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

7 January 2021

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

1 reference

7 January 2021

1 reference

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

7 January 2021

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

1 reference

7 January 2021

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

1 reference

7 January 2021

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

7 January 2021

Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225].

1 reference

7 January 2021

The new liver allocation system: moving toward evidence-based transplantation policy

1 reference

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

7 January 2021

Results of the first year of the new liver allocation plan

1 reference

7 January 2021

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients

1 reference

7 January 2021

Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.

1 reference

7 January 2021

Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection

1 reference

7 January 2021

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

1 reference

7 January 2021

Assessment of the renin-angiotensin system in cirrhotic patients

1 reference

7 January 2021

Circulating levels of endothelin in cirrhosis

1 reference

7 January 2021

Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2in cirrhosis. Relationship to functional renal failure and sodium and water excretion

1 reference

7 January 2021

Hyponatremia in cirrhosis: from pathogenesis to treatment

1 reference

7 January 2021

Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease

1 reference

7 January 2021

MELD: the answer or just more questions?

1 reference

7 January 2021

Is the change in MELD score a better indicator of mortality than baseline MELD score?

1 reference

7 January 2021

[The MELD system and organ allocation policy: lessons after the first year of use in the United States]

1 reference

7 January 2021

MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes

1 reference

7 January 2021

Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites

1 reference

7 January 2021

Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: Prognostic value of resistive index

1 reference

7 January 2021

A prognostic model for predicting survival in cirrhosis with ascites.

1 reference

7 January 2021

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

1 reference

7 January 2021

Factors determining renal response to water immersion in non-excretor cirrhotic patients

1 reference

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

7 January 2021

Pathogenesis of ascites in cirrhosis

1 reference

7 January 2021

Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.

1 reference

7 January 2021

Cardiac dysfunction in spontaneous bacterial peritonitis: A manifestation of cirrhotic cardiomyopathy?

1 reference

7 January 2021

Management of hepatorenal syndrome: another piece of the puzzle

1 reference

7 January 2021

Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)

1 reference

7 January 2021

Hepatorenal syndrome in cirrhosis: pathogenesis and treatment

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20687

1 reference

30 July 2017

1 reference